Skip to main content

Table 3 Summary of data on cytosolic proteome solubility

From: Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis

Mouse model

Strain background

Age assessed

Total Aβ burden assessed by CS-silver stain

# Animals

# of cytosolic proteins identified as over-represented in SDS insoluble fractions

Pairwise only

Pairwise and SAINT > 0.9

SAINT Score only

PrP.HuAβ/PS1

B6/C3

20 mo

+++

3

101

87

103

PrP.MoAβ/PS1

B6/C3

24 mo

+

2

2

0

0

Bri42Homo

B6/C3

15 mo

+++

3

9

0

5

PrP.APPsi

B6/C3

25 mo

+++

3

3

0

4

NTg

B6/C3

12 mo

1

   

16 mo

1

   

20 mo

2

   

Tet.HuAβ

B6/FVB F1

2.5 mo

3

0

0

0

Tet.HuAβ

B6/FVB F1

13 mo

+++

4

89

80

139

Tet.MoAβ

B6/FVB F1

24 mo

+++

3

131

38

48

Tet.Bri42

B6/FVB F1

7–8 mo

+++

4

32

12

15

NTg

B6/FVB F1

2.5 mo

-

2

   

13 mo

-

6a

   

24 mo

-

2

   
  1. aIncludes 4 mice that were treated with Dox for 1 or 4 weeks (2 each). The raw data used to produce this table are available as excel files in Additional files 3, 4 and 5, Tables S2, S3 and S4